Mostrar el registro sencillo del ítem

dc.contributor.authorAranaz Andrés, Jesús María
dc.contributor.authorAibar Remón, Carlos
dc.contributor.authorGea-Velázquez de Castro, María Teresa
dc.contributor.authorLimón Ramírez, Ramón
dc.contributor.authorBolúmar, Francisco
dc.contributor.authorHernández-Aguado, Ildefonso
dc.contributor.authorLópez Fresneña, Nieves
dc.contributor.authorDíaz-Agero Pérez, Cristina
dc.contributor.authorTerol García, Enrique
dc.contributor.authorMichel, Philippe
dc.contributor.authorSousa, Paulo
dc.contributor.authorLarizgoitia Jauregui, Itziar
dc.date2017
dc.date.accessioned2018-03-06T17:08:41Z
dc.date.available2018-03-06T17:08:41Z
dc.identifier.issn2044-6055
dc.identifier.urihttps://reunir.unir.net/handle/123456789/6318
dc.description.abstractBackground Adverse events (AEs) epidemiology is the first step to improve practice in the healthcare system. Usually, the preferred method used to estimate the magnitude of the problem is the retrospective cohort study design, with retrospective reviews of the medical records. However this data collection involves a sophisticated sampling plan, and a process of intensive review of sometimes very heavy and complex medical records. Cross-sectional survey is also a valid and feasible methodology to study AEs. Objectives The aim of this study is to compare AEs detection using two different methodologies: cross-sectional versus retrospective cohort design. Setting Secondary and tertiary hospitals in five countries: Argentina, Colombia, Costa Rica, Mexico and Peru. Participants The IBEAS Study is a cross-sectional survey with a sample size of 11 379 patients. The retrospective cohort study was obtained from a 10% random sample proportional to hospital size from the entire IBEAS Study population. Methods This study compares the 1-day prevalence of the AEs obtained in the IBEAS Study with the incidence obtained through the retrospective cohort study. Results The prevalence of patients with AEs was 10.47% (95% CI 9.90 to 11.03) (1191/11 379), while the cumulative incidence of the retrospective cohort study was 19.76% (95% CI 17.35% to 22.17%) (215/1088). In both studies the highest risk of suffering AEs was seen in Intensive Care Unit (ICU) patients. Comorbid patients and patients with medical devices showed higher risk. Conclusion The retrospective cohort design, although requires more resources, allows to detect more AEs than the cross-sectional design.es_ES
dc.language.isospaes_ES
dc.publisherBMJ Openes_ES
dc.relation.ispartofseries;vol. 7, nº 10
dc.relation.urihttp://bmjopen.bmj.com/content/7/10/e016546es_ES
dc.rightsopenAccesses_ES
dc.subjectScopuses_ES
dc.subjectJCRes_ES
dc.titleComparison of two methods to estimate adverse events in the IBEAS Study (Ibero-American study of adverse events): cross-sectional versus retrospective cohort designes_ES
dc.typeArticulo Revista Indexadaes_ES
reunir.tag~ARIes_ES
dc.identifier.doihttp://dx.doi.org/10.1136/bmjopen-2017-016546


Ficheros en el ítem

FicherosTamañoFormatoVer

No hay ficheros asociados a este ítem.

Este ítem aparece en la(s) siguiente(s) colección(ones)

Mostrar el registro sencillo del ítem